Δtau314 proteins are among the reported post-translationally modified tau species whose levels are elevated in AD subjects, compared to healthy individuals, and correlate with the severity of cognitive dysfunction in a variety of mouse lines modeling frontotemporal dementia [24, 43, 44]. Here, MAPT is linked to Alzheimer disease.